INTERNATIONAL PATENT: TARIS BIOMEDICAL LLC FILES APPLICATION FOR "INTRAVESICAL GEMCITABINE FOR USE IN TREATING BACILLUS CALMETTE-GUERIN (BCG)-NAIVE HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER (HR-NMIBC)"

GENEVA, March 24 -- TARIS BIOMEDICAL LLC (113 Hartwell AvenueLexington, Massachusetts 02421) filed a patent application (PCT/IB2025/059206) for "INTRAVESICAL GEMCITABINE FOR USE IN TREATING BACILLUS CALMETTE-GUERIN (BCG)-NAIVE HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER (HR-NMIBC)" on Sep 12, 2025. With publication no. WO/2026/058217, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CUTIE, Christopher (113 Hartwell AvenueLexington, Massachusetts 02421), SWEITI, Hussein (1400 McKean Rd.Spring House, Pennsylvania 19002), PA...